etoricoxib Tablets 60 mg, 90 mg, 120 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077
This privately-owned pharmaceutical company boasts a 20-year history of developing and manufacturing high-quality medicines, food supplements, and cosmetics for European and emerging markets. With a global reach through affiliates, partners, and distribution networks spanning Europe, the Middle East, North Africa, and beyond, they offer over 100 products across various therapeutic areas. Their key focus lies in aminoglycoside antibiotics, antihistamines, cartapenem antibiotics, cephalosporins, glucocorticosteroids, glycopeptide antibiotics, NSAIDs, and vitamins like Vitamin D3. They prioritize continuous improvement, quality, teamwork, honesty, integrity, innovation, and customer service while adhering to stringent GMP certifications.

Manufacturer usually replies in nan days

What is the Etoricoxib drug?

Etoricoxib is a selective COX-2 inhibitor. Etoricoxib is used to treat rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout. Etoricoxib helps to reduce the pain and inflammation in the joints and muscles of people. McOLSON Research Laboratories developed Etoricoxib; it was patented in 1996 and approved for medical use in 2002. Etoricoxib is a globally found drug; it is in use in more than eighty countries. However, in the US, the FDA has required some more safety and efficacy data for etoricoxib before it will issue approval. The etoricoxib approval indications can change by country. In the UK, Etoricoxib is authorized for the short term treatment of moderate pain after dental surgery of adults.

Etoricoxib manufacturers and wholesalers:

Etoricoxib has many brand names; the most known is Gencox. Some of the others are Algix and Tauxib in Italy, Arcox, Berrica, and Starcox in Pakistan, Arcoxia in Spain, Egypt, Saudi Arabia, Sweden, Finland, Norway, Estonia, Germany, Greece, Lithuania, Luxembourg, Chile, China, Hong Kong, Hungary, Indonesia, Ireland, Israel, and more. Torrent Pharma (UK) Ltd is the Marketing Authorisation Holder and Manufacturer. Etoricoxib suppliers market it in the form of film-coated tablets of 30 mg, 60 mg, 90 mg, and 120 mg.

Etoricoxib for sales:

Etoricoxib prices can change depending on the country. In Canada for a 90 mg film-coated tablet, Etoricoxib costs from $0.69 to $0.77 per unit. In France, for a 60 me film-coated tablet, Etoricoxib costs about 0.31€ per unit, and in the UK, for a 30 mg film-coated tablet, Etoricoxib costs about £0.47.
As Etoricoxib is a globally found drug, you may encounter fraudulent online websites that will want to sell Etoricoxib with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Etoricoxib. Those manufacturers have been through quality control procedures to assure the Etoricoxib distributors they were qualified partners. On the online platform, Etoricoxib is mostly available from the EU, India, Israel, Canada, and Argentina. Thanks to the intuitive online marketplace, you will find Etoricoxib and many other drugs quickly and efficiently. Placing an order or an inquiry has never been easier than with Pipelinepharma. Let us connect you with Etoricoxib manufacturers from wherever in the world.

How to use Etoricoxib drugs?

To treat osteoarthritis with Etoricoxib, the recommended dose for an adult patient is 30 mg once a day; it can be increased to a maximum of 60 mg once a day if needed. To treat Rheumatoid arthritis and Ankylosing spondylitis, an adult patient should take 60 mg once a day, increased to a maximum of 90 mg once a day if needed.
Following an Etoricoxib treatment can cause some side effects. The most common ones include stomach pain, dry socket, swelling of the legs and, or feet due to fluid retention, dizziness, headache, palpitations, irregular heart rhythm (arrhythmia), increased blood pressure.